Oncologie nieuws
- Bee Venom: Yesterday's Enemy Becomes Modern Medicine for Skin Cancer
- Reshaping the immune microenvironment and reversing immunosenescence by natural products: prospects for immunotherapy in gastric cancer
- Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial
- Co-located cell types help drive aggressive brain tumors
- Personalized cancer treatment using 3D bioprinting technology
- Gastrointestinal: White Granules in the Stomach Caused by Lymphangitis Carcinomatosis From Signet?Ring Cell Gastric Carcinoma
- Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
- [Perspectives] Health, rights, and work on the margins
- [Department of Error] Department of Error
- [Department of Error] Department of Error
- Fear of breast cancer recurrence: Impact and coping with being in a dark place
- VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target
- Correspondence to: “Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations”, Curik N et al. Leukemia. 2024; 38: 1415–1418
- High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
- RE: Long-term survival across breslow thickness categories: Findings from a population-based study of 210 042 Australian melanoma patients